Condition: Chronic Kidney Disease (Stages 4 and 5) · Peritoneal Dialysis (PD) · Sponsor: Hospital Universitario Dr. Jose E. Gonzalez
The goal of this clinical trial is to learn if synbiotics work to lower inflammation in adults with chronic kidney disease who are on peritoneal dialysis. Synbiotics are daily capsules that contain a mix of probiotics (good bacteria) and prebiotics (fiber that feeds good bacteria). The main questions it aims to answer are: Do synbiotics lower the level of inflammation markers in the blood? Do synbiotics improve the nutritional status of the participants? Do synbiotics lower the number of peritonitis (peritoneal infections) episodes? Researchers will compare synbiotics to a placebo to see if the treatment works. A placebo is a look-alike capsule that contains no active ingredients. Participants will: Take 1 capsule every day for 6 months Visit the clinic at the start, at 3 months, and at 6 months for blood tests and nutrition checkups
This description comes directly from the study's public registry record.
Elisa María Guadalupe Guerrero González, MD · 528182803788 · eguerrerog@uanl.edu.mx
Giovanna Yazmín Arteaga Müller, MD, PhD · 528112512168 · giomuller@gmail.com
Always discuss trial participation with your own doctor first.
| Hospital Universitario Dr. José E. González, Centro Regional de Enfermedades Renales (CRER) | Monterrey, Nuevo León, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07694791